NYMOX PHARMACEUTICAL Stock Quote

$3.76 arrow  Change: 0.08 %Chge: 2.17% Vol: 3,973
End Of Day Prices
High: 3.8 | Low: 3.68 | Open: 3.72 | Close: 3.76
52 Wk High: 5.1 | 52 Wk Low: 2.68 | Todays Pivot: 3.75
Sector: add stock to watch list

NYMX Chart


You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Online News For Nymox Pharmaceutical

Nymox Fexapotide Symposium And Panel Discussion At American Urological Association North Central Sectional Annual Meeting In Scottsdale

HASBROUCK HEIGHTS, N.J., Nov. 16, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the Symposium which was held on Fexapotide Triflutate studies at the Annual Meeting of the American Urological Association ...


Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association North ...

HASBROUCK HEIGHTS, N.J., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report that a Symposium on Fexapotide Triflutate studies will be held at the Annual Meeting of the American Urological Association North ...


Symposium and Panel Discussion on Nymox's Fexapotide To Be Held at American Urological Association

HASBROUCK HEIGHTS, N.J., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report that a Symposium on Fexapotide Triflutate studies will be held at the Annual Meeting of the American Urological Association North ...


Nymox Reports on Symposium, Panel Discussion and Podium Presentation on Fexapotide at American Urological...

HASBROUCK HEIGHTS, N.J., Nov. 07, 2017 — Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the two data presentations which were held on Fexapotide Triflutate studies at the Annual Meeting of the American Urological Association ...


Nymox Reports on Symposium, Panel Discussion and Podium Presentation on Fexapotide at American Urological Association ...

HASBROUCK HEIGHTS, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report on the two data presentations which were held on Fexapotide Triflutate studies at the Annual Meeting of the American Urological ...



Want To Add This Quote To Your Site?

With our stock widgets you can add a Nymox Pharmaceutical quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for NYMX to choose from. Visit here to build your stock quote widget »